Cargando…
Development of thymic tumor in [LSL:Kras(G12D); Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis
Pancreatic Ductal AdenoCarcinoma (PDAC) represents about 90% of pancreatic cancers. It is one of the most aggressive cancer, with a 5-year survival rate below 10% due to late diagnosis and poor therapeutic efficiency. This bad prognosis thus encourages intense research in order to better understand...
Autores principales: | Liot, Sophie, El Kholti, Naïma, Balas, Jonathan, Genestier, Laurent, Verrier, Bernard, Valcourt, Ulrich, Lambert, Elise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302691/ https://www.ncbi.nlm.nih.gov/pubmed/34302028 http://dx.doi.org/10.1038/s41598-021-94566-x |
Ejemplares similares
-
Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker
por: Liot, Sophie, et al.
Publicado: (2020) -
Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1‐Cre and LSL‐Kras(G12D)) mice
por: Yu, Wei, et al.
Publicado: (2021) -
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras(G12D/+);Tp53(R172H/+) (KPC) mice, a genetically engineered model of pancreatic cancer
por: Vilimas, Tomas, et al.
Publicado: (2018) -
LSL-Kras(G12D); LSL-Trp53(R172H/+); Ink4(flox/+); Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer
por: Ma, Lixiang, et al.
Publicado: (2017) -
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
por: Liot, Sophie, et al.
Publicado: (2021)